Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
T Dalton, P Cegielski, S Akksilp, L Asencios, JC Caoili… - The Lancet, 2012 - thelancet.com
Background The prevalence of extensively drug-resistant (XDR) tuberculosis is increasing
due to the expanded use of second-line drugs in people with multidrug-resistant (MDR) …
due to the expanded use of second-line drugs in people with multidrug-resistant (MDR) …
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical …
…, C Kvasnovsky, TE Tupasi, JC Caoili… - The Lancet Infectious …, 2017 - thelancet.com
Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis
are emerging worldwide. The Green Light Committee initiative supported programmatic …
are emerging worldwide. The Green Light Committee initiative supported programmatic …
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised …
…, L Domente, E Variava, J Caoili… - The Lancet …, 2019 - thelancet.com
Background Delamanid is one of two recently approved drugs for the treatment of multidrug-resistant
tuberculosis. We aimed to evaluate the safety and efficacy of delamanid in the first …
tuberculosis. We aimed to evaluate the safety and efficacy of delamanid in the first …
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two …
…, R Akksilp, J Bayona, MC Becerra, J Caoili… - The Lancet …, 2015 - thelancet.com
Background Sputum culture conversion is often used as an early microbiological endpoint in
phase 2 clinical trials of tuberculosis treatment on the basis of its assumed predictive value …
phase 2 clinical trials of tuberculosis treatment on the basis of its assumed predictive value …
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis
…, LN Chernousova, MP Chen, JC Caoili… - Clinical Infectious …, 2014 - academic.oup.com
Background. Increasing access to drugs for the treatment of multidrug-resistant (MDR)
tuberculosis is crucial but could lead to increasing resistance to these same drugs. In 2000, the …
tuberculosis is crucial but could lead to increasing resistance to these same drugs. In 2000, the …
Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance
…, J Brand, J Ershova, T Tupasi, JC Caoili… - Clinical Infectious …, 2016 - academic.oup.com
Background. Resistance to second-line drugs develops during treatment of multidrug-resistant
(MDR) tuberculosis, but the impact on treatment outcome has not been determined. …
(MDR) tuberculosis, but the impact on treatment outcome has not been determined. …
Delamanid central nervous system pharmacokinetics in tuberculous meningitis in rabbits and humans
…, JA Tornheim, P Chawla, JC Caoili… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Central nervous system tuberculosis (TB) is devastating and affects vulnerable populations.
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculous meningitis (TBM…
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculous meningitis (TBM…
[HTML][HTML] Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study
CM Yuen, EV Kurbatova, T Tupasi, JC Caoili… - PLoS …, 2015 - journals.plos.org
Background For treating multidrug-resistant tuberculosis (MDR TB), the World Health
Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be …
Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be …
[HTML][HTML] Weight gain and response to treatment for multidrug-resistant tuberculosis
MT Gler, R Guilatco, JC Caoili, J Ershova… - The American journal …, 2013 - ncbi.nlm.nih.gov
Alternatives to culture are needed in high burden countries to assess whether response to
treatment of multidrug-resistant-tuberculosis (MDR-TB) is satisfactory. The objective was to …
treatment of multidrug-resistant-tuberculosis (MDR-TB) is satisfactory. The objective was to …
Long COVID in low-income and middle-income countries: the hidden public health crisis
The COVID-19 pandemic exposed crucial fault lines in society both within and between
different societies. Over the past 3 years, inequity has been highlighted in several areas …
different societies. Over the past 3 years, inequity has been highlighted in several areas …